Skip to main content
. 2015 Jan 20;2015(1):CD001843. doi: 10.1002/14651858.CD001843.pub5

Comparison 10. Prevention of UI after radical: one active treatment versus another active treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Number of incontinent men at < 3months 3   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 PFMT pre and post op vs PFMT post op 2 289 Risk Ratio (M‐H, Fixed, 95% CI) 0.86 [0.69, 1.06]
1.2 PFMT + Biofeedback + transcutaneous Estim versus Estim only 1 54 Risk Ratio (M‐H, Fixed, 95% CI) 0.88 [0.61, 1.26]
1.3 PFMT + Biofeedback + transcutaneous Estim versus post‐op PFMT 1 54 Risk Ratio (M‐H, Fixed, 95% CI) 0.80 [0.57, 1.11]
1.4 Post‐op transcutaneous Estim versus post‐op PFMT 1 52 Risk Ratio (M‐H, Fixed, 95% CI) 0.90 [0.67, 1.22]
2 Number of incontinent men within 3 to 6 months 4   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 PFMT pre and post op vs PFMT post op 2 290 Risk Ratio (M‐H, Fixed, 95% CI) 0.75 [0.54, 1.04]
2.2 post‐op PFMT + biofeedback + transcutaneous Estim vs post‐op Estim 1 54 Risk Ratio (M‐H, Fixed, 95% CI) 1.55 [0.96, 2.49]
2.3 PFMT + general exercise versus PFMT alone 1 49 Risk Ratio (M‐H, Fixed, 95% CI) 0.48 [0.23, 0.99]
2.4 Post‐op PFMT + transcutaneous Estim + Biofeedback versus post‐op PFMT 1 54 Risk Ratio (M‐H, Fixed, 95% CI) 1.09 [0.76, 1.57]
2.5 Post‐op transcutaneous electrical stimulation versus post‐op PFMT 1 52 Risk Ratio (M‐H, Fixed, 95% CI) 0.71 [0.43, 1.16]
3 Number of incontinent men within 6 to 12 months 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3.1 PFMT pre and post op vs PFMT post op 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 post‐op PFMT + Biofeedback + transcutaneous Estim vs post‐op Estim 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Post‐op PFMT + transcutaneous Estim + Biofeedback versus post‐op PFMT 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Post‐op transcutaneous Estim versus post‐op PFMT 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of incontinent men after 12 months 4   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
4.1 PFMT pre and post op vs PFMT post op 3 367 Risk Ratio (M‐H, Fixed, 95% CI) 1.32 [0.78, 2.25]
4.2 PFMT + Penile vibration pre and post op versus PFMT pre and post op 1 58 Risk Ratio (M‐H, Fixed, 95% CI) 1.4 [0.25, 7.77]
5 No. with severe incontinence (e.g. pad test weight >150g) at < 3 months 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
5.1 PFMT pre and post op vs PFMT post op 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 No. with severe incontinence (e.g. pad test weight >150g) at 3 to 6 months 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
6.1 PFMT pre and post op vs PFMT post op 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 20 minute pad test (grams of urine lost): within 3 to 6 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 PFMT + anal EStim vs PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 PFMT + anal EStim + BF vs PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 PFMT + anal EStim vs PFMT + anal EStim + BF 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 20 minute pad test (grams of urine lost): within 6 to 12 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 PFMT + anal EStim vs PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 PFMT + anal EStim + BF vs PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 PFMT + anal EStim vs PFMT + anal EStim + BF 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 1 hour pad test (grams of urine lost) at less than 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Pre‐op PFMT + Estim versus pre‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 1 hour pad test (grams of urine lost) within 3‐6 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 Pre‐op PFMT + electrical stimulation versus pre‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 1 hour pad test within 6‐12 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 Pre‐op PFMT + electrical stimulation versus pre‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 24 hour pad test (grams of urine lost) at less than 3 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 PFMT + Biofeedback + transcutaneous Estim versus Estim only 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 Post‐operative PFMT + transcutaneous Estim + Biofeedback versus post‐operative PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Post‐operative transcutaneous electrical stimulation versus post‐operative PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 24 hour pad test (grams of urine lost) within 3‐6 months 2   Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 PFMT + Biofeedback + transcutaneous Estim versus Estim only 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 Postoperative PFMT + biofeedback + transcutaneous Estim versus postoperative PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 Post‐operative transcutaneous Estim only versus post‐operative PFMT only 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.4 PFMT + general exercise versus PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 24 hour pad test (grams of urine lost) within 6‐12 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
14.1 PFMT + transcutaneous Estim + biofeedback versus Estim only 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 Post‐op PFMT + transcutaneous Estim + Biofeedback versus post‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 Post‐op transcutaneous Estim versus post‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Quality of Life Score (ICS male short form) at < 3 months 2   Mean Difference (IV, Fixed, 95% CI) Totals not selected
15.1 PFMT pre and post op vs PFMT post op 2   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Urinary Incontinence Quality of Life Score (ICIQ ‐ short form) within 3‐6 months 3   Mean Difference (IV, Fixed, 95% CI) Totals not selected
16.1 Pre‐op PFMT + electrical stimulation versus pre‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.2 PFMT + general exercise versus PFMT alone 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 PFMT pre and post op vs PFMT post op 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Urinary Incontinence Quality of Life Score (ICIQ‐short form) within 6‐12 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
17.1 Pre‐op PFMT + electrical stimulation versus pre‐op PFMT 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 King's health Questionnaire after 12 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
18.1 General Health 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 Role limitations 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 Physical limitations 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.4 Social limitations 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.5 Personal 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.6 Emotional 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.7 Sleep/energy disturbance 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.8 Symptom severity 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Health status measure SF‐36 within 3‐6 months 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
19.1 Physical composite score 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 Mental Composite score 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Adverse events 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
20.1 PFMT pre and post op vs PFMT post op 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 PFMT + Penile vibration pre and post op versus PFMT pre and post op 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]